Skip to main content

Table 1 Baseline patient characteristics by geographical region

From: Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study

Ā 

All

China

South Asia

East Asia

North Africa

Middle East

Latin America

Russia

All patients

Ā Ā Ā Ā Ā Ā Ā Ā 

Age, yr

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

65,381

10,889

21,775

9,966

4,011

14,549

1,126

3,065

ā€ƒā€‰mean (SD)

54.0 (12.0)

54.9 (14.7)

51.7 (10.2)

56.5 (12.1)

58.1 (11.8)

52.5 (11.4)

59.5 (12.9)

59.2 (9.2)

Sex

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

66,656

11,019

22,436

10,030

4,032

14,927

1,138

3,074

ā€ƒā€‰male (%)

37,033 (55.6)

6,300 (57.2)

13,908 (62.0)

5,092 (50.8)

1,717 (42.6)

8,636 (57.9)

485 (42.6)

895 (29.1)

BMI, kg/m2

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

59,115

10,817

19,292

8,664

3,611

12,571

1,092

3,068

ā€ƒā€‰mean (SD)

27.1 (5.0)

24.7 (3.4)

26.3 (3.8)

24.8 (4.3)

28.0 (5.0)

30.4 (5.5)

29.4 (5.6)

31.1 (5.3)

Diabetes duration, yr

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

65,786

10,814

22,316

9,776

4,016

14,658

1,135

3,071

ā€ƒā€‰mean (SD)

8.0 (6.2)

6.3 (6.3)

6.4 (4.7)

8.6 (6.9)

11.5 (7.2)

9.8 (6.0)

12.0 (8.3)

8.4 (5.4)

Patients with macrovascular complications

Ā Ā Ā Ā Ā Ā Ā Ā 

Age, yr

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

17,506

2,318

4,806

2,662

972

4,195

333

2,220

ā€ƒā€‰mean (SD)

59.3 (10.6)

61.7 (14.1)

56.3 (8.9)

61.5 (10.6)

63.6 (9.5)

57.7 (10.1)

65.1 (9.9)

61.0 (8.5)

Sex

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

17,786

2,342

4,943

2,684

978

4,278

335

2,226

ā€ƒā€‰male (%)

9,618 (54.1)

1,271 (54.3)

3,178 (64.3)

1,350 (50.3)

488 (49.9)

2,567 (60.0)

156 (46.6)

608 (27.3)

BMI, kg/m2

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

16,271

2,306

4,645

2,310

867

3,603

317

2,223

ā€ƒā€‰mean (SD)

27.9 (5.3)

25.1 (3.4)

26.2 (3.6)

25.3 (4.3)

28.8 (5.1)

31.1 (5.5)

30.4 (6.0)

31.6 (5.3)

Diabetes duration, yr

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

17,653

2,297

4,938

2,635

973

4,251

335

2,224

ā€ƒā€‰mean (SD)

10.3 (6.6)

9.4 (7.0)

8.4 (5.1)

10.5 (7.3)

14.2 (7.9)

12.4 (6.4)

14.6 (8.6)

9.2 (5.4)

Patients with microvascular complications

Ā Ā Ā Ā Ā Ā Ā Ā 

Age, yr

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

34,518

5,399

8,103

5,582

2,386

9,602

710

2,736

ā€ƒā€‰mean (SD)

56.9 (11.2)

57.9 (14.1)

54.8 (9.7)

59.0 (11.2)

60.9 (10.5)

54.6 (10.4)

61.0 (12.1)

59.8 (8.9)

Sex

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

35,033

5,467

8,288

5,614

2,395

9,810

715

2,744

ā€ƒā€‰male (%)

18,542 (52.9)

2,957 (54.1)

5,067 (61.1)

2,752 (49.0)

994 (41.5)

5,703 (58.1)

293 (41.0)

776 (28.3)

BMI, kg/m2

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

31,894

5,364

7,644

4,946

2,154

8,361

686

2,739

ā€ƒā€‰mean (SD)

27.6 (5.3)

24.7 (3.4)

26.1 (3.7)

25.0 (4.3)

28.4 (5.0)

30.9 (5.5)

29.4 (5.7)

31.2 (5.3)

Diabetes duration, yr

Ā Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰n

34,666

5,371

8,281

5,514

2,379

9,667

712

2,742

ā€ƒā€‰mean (SD)

9.9 (6.4)

8.4 (6.7)

8.2 (4.9)

10.4 (7.2)

13.6 (7.3)

11.2 (6.0)

13.7 (8.3)

8.9 (5.4)

  1. Note: due to the observational nature of this study, not all baseline data were recorded.
  2. BMIā€‰=ā€‰body mass index.